Skip Navigation

Your Environment. Your Health.

Emerging Biomarkers of Inflammation

The NIEHS Cross-Division Implementation on Inflammation Faculty Seminar & Webcast Series
February 5, 2015

Purpose

NIEHS and the environmental health sciences community have made great strides in identifying and understanding the role of environment in health and disease. The NIEHS Strategic Plan attempts to build on these efforts in the field of inflammation by understanding: (Goal 1) fundamental shared mechanisms involved in the development of immune-mediated inflammation related diseases; (Goal 2) individual susceptibility and complex inflammatory diseases resulting from environmental factors; (Goal 4) how combined exposures affect disease pathogenesis; (Goal 7) create a collaborative environment across trans-NIEHS divisions; and (Goal 8) how to increase scientific literacy and awareness of inflammation-related environmental exposures and health consequences. In order to achieve these goals, NIEHS launched the Inflammation Faculty and Working Group Seminar Series to provide a forum to review and highlight ongoing and planned research activities on inflammation, with a particular focus on the role of the environment in these processes.

Agenda

Date: February 5, 2015

Speaker 1: Thomas J. Wang, M.D. – Vanderbilt Heart and Vascular Institute "Biomarkers of Cardiovascular Disease"

Speaker 2: Russell Bowler, M.D., Ph.D. – National Jewish Health "Emerging Biomarkers of Inflammation in Chronic Obstructive Lung Disease"

Speaker 3: Junfeng (Jim) Zhang, Ph.D. – Duke Global Health Institute "The Utility of Inflammatory Biomarkers in Studies of Air Pollution Health Effects"

Panelists:
Frederick Miller, M.D., Ph.D.
Andrew Rooney, Ph.D.
Shepherd Schurman, M.D.
Sven Eric Jordt, Ph.D.
Bonnie Joubert, Ph.D.

Abstract

Inflammation has been recognized to play a key role in the pathology of a number of human diseases. The overall aim of this webcast is to learn emerging advances from the cardiovascular and pulmonary fields explicating identification and/or validation of robust and predictive markers, or patterns or clusters of inflammatory markers in relation to environmental disease, and can be further used to assess inflammation in the general population. We are pleased to host Dr. Thomas J. Wang, M.D., Professor of Medicine and Director of Cardiovascular Medicine, Vanderbilt Heart and Vascular Institute; Dr. Russell Bowler, M.D., Ph.D., Professor of Medicine, Division of Pulmonary, Critical Care & Sleep Medicine, National Jewish Health; and Dr. Junfeng (Jim) Zhang, Ph.D., Professor of Global and Environmental Health, Duke Global Health Institute, who will present discussions on novel biomarkers of cardiometabolic risk, new data on the role of biomarkers in smoking related to lung disease along with biomarkers of systemic inflammatory mechanisms related to climate and air pollution. A panel discussion consisting of NIEHS intramural, extramural and toxicology panelists will take place to facilitate thoughts on translational implications on human health from a divisional perspective, challenges in the field, and so forth.